Enhancement of 25-(OH)D-1α-OHase activity will add to availability of 1,25-(OH)2D3 in the gut epithelium and consequently lessen the tumorigenic potential of COX-2, while simultaneous down-regulation of CYP24A1 could reduce the risk of further tumor progression. The gene discussed is CYP24A1; the disease is neoplasm.